Concepedia

The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

Adam M. Deane, Marianne J. Chapman, Robert Fraser, Carly M. Burgstad, Laura K. Besanko, Michael Horowitz

Critical Care · 2009 · 89 citations · 14 references

DOIFull text

Open access

Abstract

Australian New Zealand Clinical Trials Registry number: ACTRN12609000093280.

References

14

Intensive Insulin Therapy in Critically Ill Patients

Greet Van den Berghe, Pieter Wouters, Frank Weekers et al. · New England Journal of Medicine · 2001 · 10K citations · Full text

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine · 2008 · 7.8K citations · Full text

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis

Frank M. Brunkhorst, Christoph Engel, Frank Bloos et al. · New England Journal of Medicine · 2008 · 2.9K citations · Full text

Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes

Guillermo E. Umpierrez, Scott Isaacs, Niloofar Bazargan et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 2.1K citations

, , +19

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

, , +18